The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
A clinical update of using albumin as a drug vehicle — A commentary
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
All About Albumin: Biochemistry, Genetics, and Medical Applications
Peters, T. (1995) · Thammasat University Digital Collections · Cited by 3,090
Peters, T. (1985) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60065-0 · Cited by 2,181
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Self-citationVon Hoff, D. D., Ramanathan, R. K., Borad, M. J., Laheru, D. A., Smith, L. S., Wood, T. E., Korn, R. L., Desai, N., Trieu, V., Iglesias, J. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.5742 · Cited by 1,044
Impact of albumin on drug delivery — New applications on the horizon
Elsadek, B., & Kratz, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 832
Self-citationProtein nanoparticles as drug carriers in clinical medicine
Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779
Socinski, M. A., Bondarenko, I., Karaseva, N. A., Makhson, A. M., Vynnychenko, I., Okamoto, I., Hon, J. K., Hirsh, V., Bhar, P., Zhang, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5848 · Cited by 756
Desai, N., Trieu, V., Damascelli, B., & Soon-Shiong, P. (2009) · Translational Oncology · doi:10.1593/tlo.09109 · Cited by 396
Tiruppathi, C., Song, W., Bergenfeldt, M., Sass, P., & Malik, A. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25968 · Cited by 391
Size and Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial Cells
Wang, Z., Tiruppathi, C., Minshall, R. D., & Malik, A. B. (2009) · ACS Nano · doi:10.1021/nn9012274 · Cited by 319
Kratz, F., Warnecke, A., Scheuermann, K., Stockmar, C., Schwab, J., Lazar, P., Drückes, P., Esser, N., Drevs, J., Rognan, D., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020276c · Cited by 275
Self-citationSage, H., Johnson, C., & Bornstein, P. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43194-2 · Cited by 265
Podhajcer, O. L., Benedetti, L. G., Girotti, M. R., Prada, F., Salvatierra, E., & Llera, A. S. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9146-7 · Cited by 236
Schnitzer, J. E. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.1.h246 · Cited by 217
Kratz, F., Müller-Driver, R., Hofmann, I., Drevs, J., & Unger, C. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9905864 · Cited by 166
Self-citationPrognostic factors in patients with recently diagnosed incurable cancer: a systematic review
Hauser, C. A., Stockler, M. R., & Tattersall, M. H. N. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0079-9 · Cited by 144
Kratz, F., & Warnecke, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.045 · Cited by 136
Self-citationHersh, E. M., O'Day, S. J., Ribas, A., Samlowski, W. E., Gordon, M. S., Shechter, D. E., Clawson, A., & Gonzalez, R. C. (2009) · Cancer · doi:10.1002/cncr.24720 · Cited by 119
Phase I and Pharmacokinetic Study of the (6-Maleimidocaproyl)Hydrazone Derivative of Doxorubicin
Unger, C., Häring, B., Medinger, M., Drevs, J., Steinbild, S., Kratz, F., & Mross, K. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2776 · Cited by 104
Self-citationGraeser, R., Esser, N., Unger, H., Fichtner, I., Zhu, A., Unger, C., & Kratz, F. (2009) · Investigational New Drugs · doi:10.1007/s10637-008-9208-2 · Cited by 70
Self-citationKratz, F., Azab, S. S., Zeisig, R., Fichtner, I., & Warnecke, A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.003 · Cited by 25
Self-citation
Cited by
Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide
Lau, J., Bloch, P., Schäffer, L., Pettersson, I., Spetzler, J., Kofoed, J., Madsen, K., Knudsen, L. B., McGuire, J., Steensgaard, D. B., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00726 · Cited by 1,105
Albumin-based drug delivery: harnessing nature to cure disease
Larsen, M. T., Kuhlmann, M., Hvam, M. L., & Howard, K. A. (2016) · Molecular and Cellular Therapies · doi:10.1186/s40591-016-0048-8 · Cited by 683
Harnessing albumin as a carrier for cancer therapies
Hoogenboezem, E. N., & Duvall, C. L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.011 · Cited by 610
The Uniqueness of Albumin as a Carrier in Nanodrug Delivery
Spada, A., Emami, J., Tuszynski, J. A., & Lavasanifar, A. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00046 · Cited by 591
Multifunctional biomolecule nanostructures for cancer therapy
Wang, J., Li, Y., & Nie, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00315-x · Cited by 488
Metadata
- Authors
- Kratz, F.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 190
- Pages
- 331-336
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1968128233
- Cited by
- 334
- References
- 23
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.